2006
DOI: 10.1080/13697130600955229
|View full text |Cite
|
Sign up to set email alerts
|

Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 5 publications
(3 reference statements)
0
2
0
Order By: Relevance
“…MacLennnan and Sturdee argued that monitoring is not required. 53 There are two elements to their argument. The first is that endometrial screening is costly and has low specificity; the second is that the risk of endometrial cancer after vaginal estrogen use is undefined.…”
Section: Vaginal Estrogen and The Endometriummentioning
confidence: 99%
See 1 more Smart Citation
“…MacLennnan and Sturdee argued that monitoring is not required. 53 There are two elements to their argument. The first is that endometrial screening is costly and has low specificity; the second is that the risk of endometrial cancer after vaginal estrogen use is undefined.…”
Section: Vaginal Estrogen and The Endometriummentioning
confidence: 99%
“…In addition, endometrial cancers often present with vaginal bleeding which makes detection easier. 53 The Cochrane Database does not show evidence of endometrial proliferation or cancers with unopposed low dose vaginal estrogen but there have been no long term studies. It does suggest that progesterone should be added if there is systemic absorption as suggested by administration of greater than 0.5 mg/day.…”
Section: Vaginal Estrogen and The Endometriummentioning
confidence: 99%